Melola Discovery

← Melola Discovery

Akses terbuka Jurnal SINTA 1

THE BENEFIT AND RISK OF MISOPROSTOL USE: IN OBSTETRICS AND GYNECOLOGY

Jurnal kedokteran dan kesehatan Indonesia · Vol. 7 No. 1 (2015) · hlm. 25–29

DOI
10.20885/jkki.vol7.iss1.art5
ISSN
2085-4145, 2527-2950
Terbit
2015-05-20
Penerbit
Islamic University of Indonesia
Bahasa
en
Lisensi
creativecommons.org/licenses/by/4.0/

Abstrak

Misoprostol is licensed to treat gastric ulcers but now it is widely used for a variety of indications in osbtetrics and gynecology. This is called ‘off-label’ use. Misoprostol is cheap, stable at room temperature and easily to access it. Available in tablet form, it can be administred vaginally, rectally, sublingually and bucally. This review explains benefit and risk of misoprostol in obstetric and gynecology field.

Kata kunci

Jaringan kolaborasi para penulis

2 penulis · 1 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Islamic University of Indonesia
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
Addiniya Nurul AzmiIslamic University of Indonesia1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210214198, pertama di-harvest 20 Nov 2026, terakhir terlihat 20 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">THE BENEFIT AND RISK OF MISOPROSTOL USE: IN OBSTETRICS AND GYNECOLOGY</dc:title><dc:creator>Sufi Desrini</dc:creator><dc:subject>misoprostol</dc:subject><dc:subject>off-label drug use</dc:subject><dc:subject>obstetric indications</dc:subject><dc:subject>drug benefits and risks</dc:subject><dc:subject>gastric ulcer treatment</dc:subject><dc:subject>vaginal administration</dc:subject><dc:subject>rectal administration</dc:subject><dc:subject>sublingual administration</dc:subject><dc:subject>buccal administration</dc:subject><dc:description xml:lang="en">Misoprostol is licensed to treat gastric ulcers but now it is widely used for a variety of indications in osbtetrics and gynecology. This is called ‘off-label’ use. Misoprostol is cheap, stable at room temperature and easily to access it. Available in tablet form, it can be administred vaginally, rectally, sublingually and bucally. This review explains benefit and risk of misoprostol in obstetric and gynecology field.</dc:description><dc:publisher>Islamic University of Indonesia</dc:publisher><dc:date>2015-05-20</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20885/jkki.vol7.iss1.art5</dc:identifier><dc:identifier>10.20885/jkki.vol7.iss1.art5</dc:identifier><dc:source>Jurnal kedokteran dan kesehatan Indonesia; Vol 7 No 1 (2015); 25-29</dc:source><dc:source>2085-4145</dc:source><dc:source>2527-2950</dc:source><dc:language>en</dc:language><dc:relation>https://journal.uii.ac.id/JKKI/article/view/3685/3264</dc:relation><dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights></oai_dc:dc>